Search clinical trials for: Sitagliptin phosphate

Total 4000 results

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
IlDong Pharmaceutical Co Ltd

Recruiting

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Type 2 Diabetes

Germany
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

Type 2 Diabetes Mellitus

Brazil
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

Type 2 Diabetes

Germany
Tufts Medical Center

Completed

Topical Ruxolitinib for the Treatment of Vitiligo

Vitiligo

United States
University of Copenhagen
Stine Kristensen; Gita Krüger Mørch; Rizwan Butt; Ditte Hansen

Not yet recruiting

a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients (RCTOIP)

Chronic Kidney Disease Requiring Chronic Dialysis

Denmark
I.M. Sechenov First Moscow State Medical University
Central Scientific Research Institute of Dentistry and Maxillo-facial Surgery... and other collaborators

Completed

Ridge Preservation With New Class of Osteoplastic Materials (RP)

Tooth Extraction | Atrophy of Edentulous Alveolar Ridge

Russian Federation
Boehringer Ingelheim

Completed

Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers

Healthy
Vanderbilt University

Completed

Effect of DPP4 Inhibition on Vasoconstriction

Type 2 Diabetes Mellitus

United States
Services Hospital, Lahore

Completed

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

Diabetes, Type 2

Pakistan
Vanderbilt University

Completed

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Hypertension | Type 2 Diabetes Mellitus

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma

United States
Yale University
National Center for Advancing Translational Sciences (NCATS)

Suspended

The Impact of Phosphate Metabolism on Healthy Aging

Rickets | Hypophosphatemia | Hypercalciuria | XLH | HHRH

United States
Ono Pharmaceutical Co. Ltd
MSD K.K.

Completed

MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study in Patients With Type 2 Diabetes

Type 2 Diabetes

Japan
Sun Yat-sen University

Completed

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects (LIGHT-ON)

Non-alcoholic Fatty Liver Disease

China
Hadassah Medical Organization

Unknown

Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy

Diabetes Mellitus | Iron Metabolism Disorders | Optic Atrophy | Sensorineural Hearing Loss | Platelet Dysfunction | Gastroduodenal Ulcer

Israel
St. Jude Children's Research Hospital
Thrasher Research Fund

Terminated

Trial of Oral Glutamine in Patients With Sickle Cell Anemia

Anemia, Sickle Cell

United States
DiMango, Emily, M.D.
Novartis; Genentech, Inc.

Completed

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

Asthma

United States
National Center for Research Resources (NCRR)
Children's National Research Institute

Completed

A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)

Muscular Dystrophy, Duchenne

United States
Trius Therapeutics LLC

Completed

Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) (IV/SAD/MAD)

Bacterial Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Type 2 Diabetes Mellitus
University of Copenhagen
Camilla Storm Slumstrup; Ewa Lewin; Casper Rydahl

Completed

Effect of a Phosphate Modified Diet on Phosphate Balance and Phosphate Metabolism in Predialysis Patients Stage 3-4

Chronic Kidney Disease

Denmark
Boehringer Ingelheim
Eli Lilly and Company

Completed

Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan
AstraZeneca

Completed

Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)

Type 2 Diabetes Mellitus

United States
Merck Sharp & Dohme LLC
Pfizer

Completed

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Type 2 Diabetes Mellitus
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Allergic Asthma

Japan
Ajou University School of Medicine

Unknown

Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients

Asthma
Genentech, Inc.

Completed

A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g

Peanut Hypersensitivity
Beijing Tongren Hospital

Completed

The Efficacy of Preseasonal Omalizumab Treatment

Seasonal Allergic Rhinitis

China
University of Arkansas

Terminated

Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

Breast Cancer

United States
Novartis
Daiichi Sankyo Co., Ltd.

Completed

Study of Omalizumab in Moderate to Severe Bronchial Asthma

Asthma
Jens Rikardt Andersen

Completed

Absorption of Orally Ingested Phosphate in Refeeding Syndrome

Refeeding Syndrome | Cancer of the Head and Neck

Denmark
Laboratoires Mayoly Spindler

Completed

Measurement of Gastric Emptying During and After COLOKIT® Intake

Colonoscopy

France
Dong Wha Pharmaceutical Co. Ltd.

Completed

the Pharmacokinetic Profiles of Linagliptin With DW1029M (PLID)

Healthy

Korea, Republic of
Merck Sharp & Dohme LLC
Pfizer

Completed

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)

Type 2 Diabetes Mellitus
Boehringer Ingelheim
Eli Lilly and Company

Completed

30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks

Diabetes Mellitus, Type 2

United States, Estonia, Germany, Latvia, Spain, United Kingdom
Neuralstem Inc.

Completed

Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189

Depression

United States
Weill Cornell Medical College in Qatar
University of Hull; Hamad Medical Corporation; Sidra Medical and Research Center

Active, not recruiting

HbA1c Variability in Type II Diabetes

Diabetes Mellitus Type 2

Qatar
Emory University

Completed

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

Hyperglycemia

United States
Merck Sharp & Dohme LLC

Completed

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Diabetes Mellitus, Type 2
Taipei Medical University Hospital

Recruiting

The Causal Connection Between Sng and Muscle Acidosis

Muscle Acidosis

Taiwan
Boehringer Ingelheim

Completed

Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects

Healthy
Peking Union Medical College Hospital
Chinese Academy of Sciences

Unknown

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Type2 Diabetes Mellitus

China
Emory University

Completed

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery (SITA-CABGDM)

Hyperglycemia

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease (CONNECT-IBD)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis

France, Spain, United Kingdom, Czechia, Italy, Belgium, Germany, Netherlands, Greece, Finland, Hungary, Portugal, Slovakia
Taipei Medical University Hospital

Recruiting

Effect of Flow Rate and pH on Muscle Acidosis

Muscle Acidosis

Taiwan
Hoffmann-La Roche

Completed

A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)

Asthma

United States
Ankara Education and Research Hospital

Unknown

The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy (GELUPO)

Peripheral Neuropathy

Turkey
Trius Therapeutics LLC

Completed

Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate

Healthy

United States
Clinical Evaluation Research Unit at Kingston General...

Unknown

The Impact of a Low or High Phosphate Diet on Phosphate and Calcium Excretion in Healthy People

Cardiovascular Diseases | Aging | Nutrient; Excess

Canada

Search clinical trials for: Sitagliptin phosphate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations